Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-26

Clinical Trial Update: Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating finerenone in patients with non-diabetic glomerulonephritis; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Finerenone (finerenone)

Snippet

Sponsor: Alexandria University | Conditions: Glomerulonephritis | Phase 2 | Status: RECRUITING